A meta‐analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis

AIMS: In immune‐mediated inflammatory diseases (IMIDs), early symptom control is a key therapeutic goal. Methotrexate (MTX) is the first‐line treatment across IMIDs. However, MTX is underutilized and suboptimally dosed, partly due to the inability of making individualized treatment decisions through...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Meeberg, Maartje M., Hebing, Renske C. F., Nurmohamed, Michael T., Fidder, Herma H., Heymans, Martijn W., Bouma, Gerd, de Bruin‐Weller, Marjolein S., Tekstra, Janneke, van den Bemt, Bart, de Jonge, Robert, Bulatović Ćalasan, Maja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Meta‐analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099850/
https://www.ncbi.nlm.nih.gov/pubmed/36326810
http://dx.doi.org/10.1111/bcp.15579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099850/
https://www.ncbi.nlm.nih.gov/pubmed/36326810
http://dx.doi.org/10.1111/bcp.15579

Ejemplares similares